Signature Diagnostics has named Rainer Kramer as its chief business officer. Kramer formerly was vice president of corporate business development at Jerini, and before that he worked in research and business development at MorphoSys and at Amgen.
Integromics has appointed Michael McManus as its president and CEO.
McManus most recently led GenomeQuest's corporate marketing, strategic alliances, product marketing, and development efforts. He also served as vice president of business development for the BioSciences Group at Fujitsu Computer Systems, executive VP and COO at Anvil Informatics, and VP of marketing and business development at CambridgeSoft.
Asterand has appointed Dalia Cohen to the position of chief scientific officer. Cohen joins Asterand from Rosetta Genomics, where she also served as CSO.